COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff as we address the COVID-19 situation. Learn more about COVID-19 online education, resources, and live course cancellations.

COVID-19: Updates for 2021 - Online CME Course

Course Director: Devyani Lal, M.D.

Available until February 12, 2022 - Online CME

Mayo Clinic experts will discuss the latest information on COVID-19, including clinical updates, research developments, infection control, vaccines and practical advice that healthcare professionals can use in their practice.

Please see the "Program" tab for links to a comprehensive list of lectures, podcasts, and webinars available in this course. You can watch videos of choice at no cost, or register for the segment(s) for which you wish to claim credit.

This collection of videos will be expanded as new information becomes available. Please check back often for updates.

Target Audience

Healthcare providers in all specialties who are being impacted by COVID-19, including physicians, research scientists, physician assistants, nurse practitioners, nurses, and caregivers with a particular interest in prevention, treatment and patient care.

Learning Objectives

Upon conclusion of this program, participants will be able to:

Discuss current research initiatives related to the COVID-19 pandemic
Identify promising, innovative solutions in treatment strategies for patients with COVID-19
Describe the expedited translational research related to COVID-19

Utilization of this Mayo Clinic online (enduring materials) course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be in this course.

Additional Information

Attachment	Size
Additional Information and Faculty Disclosure	137.69 KB

Course summary

Available credit:

5.25 AMA PRA Category 1 Credit™
3.75 ANCC
3.75 AOA Category 2-A
5.25 Attendance

Course opens:

02/11/2021

Course expires:

02/12/2022

	COVID-19 Vaccines: Myths, Mysteries, Misinformation, Myopia, and Miracles Recorded: 01/28/2021 1.50 CME Credit Available Gregory A. Poland, M.D., provides an in-depth look at the COVID vaccines currently on the market under the EUA and those that are still in development, including who should and should not get these vaccines. He dispels myths about vaccines and gives some insight on addressing those with patients. Dr. Poland also offers answers and insight to live listeners' questions. Click here for more information
	Going Viral: The Role of Remdesivir in COVID-19 Recorded 1/26/2021 0.50 CME Credit Available In the past year multiple different medications have been evaluated for use in COVID-19. Remdesivir is an antiviral that showed promise in SARS-CoV-2 infections early in 2020 then was subsequently FDA-approved for its use in COVID-19 in late 2020. This presentation will review the data behind remdesivir’s use and describe an ideal patient population for remdesivir. Click here for more information
	COVID-19 Webinar Series: Session 13: Supply Chain Considerations for Delivering the COVID-19 Vaccine Webinar: 01/20/2021 1.00 CME Credit Available Mayo Clinic experts discuss logistic and supply chain challenges for delivering and distributing the vaccine against COVID-19. Topics include overcoming vaccine hesitancy; ensuring vaccines reach high-priority groups first; administration of multiple doses; and adverse effect management. Click here for more information
	COVID-19: Vaccine Education and Debunking Myth Recorded: 01/19/2021 1.50 CME Credit Available A panel of experts discuss the importance of the COVID-19 vaccine, particularly in the racial/ethnic minority populations. They explain myths, distrust, and other common barriers within these communities. Click here for more information
	COVID Vaccinations: Lessons Learned at Mayo Clinic Recorded: 12/22/2020 0.25 CME Credit Available Michelle R. Holm, Pharm.D., R.Ph., M.P.H., discusses the supply chain logistics of the COVID vaccination, including obtaining, storing, and preventing diversion. Also discussed is a paper published on the topic, available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723768/. Click here for more information
	Mayo Clinic Talks COVID-19 Miniseries Episode 57: Transcending the Valley of Death - COVID-19 mRNA Vaccine Update Podcast: 12/21/2020 0.50 CME Credit Available It is projected that by March of 2021, 1:700 Americans will have died of COVID-19. The historic pace of COVID-19 vaccine development was made possible by the countless sacrifices of many individuals across healthcare, research, health and human services, the Department of Defense, and other key sectors. This interprofessional collaboration required many to set life aside and work tirelessly to bring an effective vaccine to market, quickly. While mRNA vaccines have been in development since the 1990s, the COVID-19 vaccine efficacy rate of 95-100% across studied ages, race and ethnicities, and comorbidities is unprecedented. Dr. Greg Poland breaks down everything you need to know about the mRNA COVID-19 vaccines. Click here for more information

Devyani Lal, M.D.
Course Director
Associate Dean, Mayo Clinic School of
Continuous Professional Development
Professor of Otolaryngology,
College of Medicine
Chair, Division of Rhinology
Mayo Clinic in Arizona

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):

AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 3.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

AOA
The American Osteopathic Association designates this program for a maximum of 3.75 AOA Category 2-A credits.

Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.